Harmony Accounts Payable from 2010 to 2024

HRMY Stock  USD 34.67  1.08  3.02%   
Harmony Biosciences Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount Harmony Biosciences Holdings owes to suppliers or vendors for products or services received but not yet paid for. It represents Harmony Biosciences' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-09-30
Previous Quarter
22.7 M
Current Value
10.5 M
Quarterly Volatility
5.4 M
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Harmony Biosciences Holdings over the last few years. An accounting item on the balance sheet that represents Harmony Biosciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Harmony Biosciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Harmony Biosciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Harmony Accounts Payable Regression Statistics

Arithmetic Mean4,213,833
Geometric Mean2,433,237
Coefficient Of Variation138.40
Mean Deviation4,008,667
Median1,462,000
Standard Deviation5,831,789
Sample Variance34T
Range17.6M
R-Value0.66
Mean Square Error20.7T
R-Squared0.43
Significance0.01
Slope859,084
Total Sum of Squares476.1T

Harmony Accounts Payable History

202418.6 M
202317.7 M
20223.8 M
2021M
20202.6 M
20196.4 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable17.7 M18.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.